Skip to main content

A pediatric case of hepatitis B virus subgenotype A2 in Japan

Abstract

Hepatitis B virus (HBV) has been classified into 10 major genotypes, and HBV genotypes C and B are found in the majority of Japanese patients. However, the prevalence of genotype A has been increasing in patients with chronic or acute hepatitis. Here we report a pediatric case of HBV subgenotype A2. A 2-year-old girl was referred to our hospital for liver damage caused by HBV infection. During the pregnancy, her father had developed acute sporadic hepatitis B. The child was born without any complications. She did not receive HBV vaccination at birth because her mother was negative for HBs antigen at the pre-delivery screening; however, her mother developed acute hepatitis B 2 months after delivery. At that time, HBs antigen was detected in the current patient. Phylogenetic full-length sequence analysis revealed HBV subgenotype A2. HBV sequencing was not performed for her parents; therefore, the intrafamilial transmission routes in these cases are unclear, although the authors speculate that, for the current patient, mother-to-child transmission may have occurred. This report illustrates the pitfalls of the selective vaccination strategy in Japan for preventing HBV infection. Universal vaccination to prevent HBV infection might be useful in Japan.

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002;2:395–403.

    PubMed  Article  Google Scholar 

  2. Ganem D, Prince AM. Hepatitis B virus infection–natural history and clinical consequences. N Engl J Med. 2004;350:1118–29.

    PubMed  Article  CAS  Google Scholar 

  3. Tatematsu K, Tanaka Y, Kurbanov F, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype. J Virol. 2009;83:10538–47.

    PubMed  Article  CAS  Google Scholar 

  4. Orito E, Ichida T, Sakugawa H, et al. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology. 2001;34:590–4.

    PubMed  Article  CAS  Google Scholar 

  5. Hayashi K, Katano Y, Takeda Y, et al. Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan. J Med Virol. 2007;79:366–73.

    PubMed  Article  CAS  Google Scholar 

  6. Sugauchi F, Kumada H, Acharya SA, et al. Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A. J Gen Virol. 2004;85:811–20.

    PubMed  Article  CAS  Google Scholar 

  7. Kobayashi M, Suzuki F, Arase Y, et al. Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001. J Gastroenterol. 2001;39:844–50.

    Article  Google Scholar 

  8. Yotsuyanagi H, Okuse C, Yasuda K, et al. Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan. J Med Virol. 2005;77:39–46.

    PubMed  Article  CAS  Google Scholar 

  9. Matsuura K, Tanaka Y, Hige S, et al. Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A. J Clin Microbiol. 2009;47:1476–83.

    PubMed  Article  Google Scholar 

  10. Huy TT, Ushijima H, Quang VX, et al. Genotype C of hepatitis B virus can be classified into at least two subgroups. J Gen Virol. 2004;85:283–92.

    PubMed  Article  CAS  Google Scholar 

  11. Torii Y, Kimura H, Hayashi K, et al. Causes of vertical transmission of hepatitis B virus under the at-risk prevention strategy in Japan. Microbiol Immunol. 2013;57:118–21.

    PubMed  Article  CAS  Google Scholar 

  12. Komatsu H, Sugawara H, Inui A, et al. Does the spread of hepatitis B virus genotype A increase the risk of intrafamilial transmission in Japan? J Infect Chemother. 2011;17:272–7.

    PubMed  Article  Google Scholar 

  13. Noto H, Terao T, Ryou S, et al. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980–1994. J Gastroenterol Hepatol. 2003;18:943–9.

    PubMed  Article  Google Scholar 

  14. Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008;26:6266–73.

    PubMed  Article  Google Scholar 

Download references

Conflict of interest

Hidemi Goto received a research grant from Astra Zenaca, Astellas Pharma, Ajinomoto Pharmaceutical Co., Bristol-Myers Squibb, Chugai Pharmaceutical Co., Daiichi Sankyo, Dainippon Sumitomo Pharma, Eisai, Mitsubishi Tanabe Pharma, MSD, Otsuka Pharmaceutical Co. and Takeda Pharmaceutical Co.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Masatoshi Ishigami.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hayashi, K., Ishigami, M., Ishizu, Y. et al. A pediatric case of hepatitis B virus subgenotype A2 in Japan. Clin J Gastroenterol 6, 383–385 (2013). https://doi.org/10.1007/s12328-013-0402-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-013-0402-1

Keywords

  • Hepatitis B virus
  • HBV genotype A
  • Universal vaccination